While additional studies are needed to address the impact of CRHR signaling, the altered receptor expression suggests that CRH-related peptides within the bladder mucosa may play a role in IC/BPS pathophysiology. The gene discussed is CRH; the disease is Bartsocas-Papas syndrome 1.